about
Transcriptional Targeting in Cancer Gene TherapyIn vitro non-viral gene delivery with nanofibrous scaffoldsCurrent progress in gene delivery technology based on chemical methods and nano-carriersMicrobubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells.Site-specific sonoporation of human melanoma cells at the cellular level using high lateral-resolution ultrasonic micro-transducer arrays.An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes.Fast targeted gene transfection and optogenetic modification of single neurons using femtosecond laser irradiation.Very long-chain fatty tails for enhanced transfection.Characterizing DNA condensation and conformational changes in organic solvents.Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells.N-isopropylacrylamide-modified polyethylenimines as effective gene carriers.PEI conjugated gold nanoparticles: efficient gene carriers with visible fluorescence.Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.The development of poly-L-arginine-coated liposomes for gene deliveryNanotechnology and the treatment of HIV infection.Novel molecular approaches to cystic fibrosis gene therapy.Fusion and fission of molecular assemblies of amphiphilic polypeptides generating small vesicles from nanotubes.DNA-based therapeutics and DNA delivery systems: a comprehensive review.Cell-specific targeting of lipid-based carriers for ODN and DNA.Stimuli-responsive polymers in gene delivery.Transactivating transcriptional activator-mediated drug delivery.Optimization and delivery of plasmid DNA for vaccination.Assessment of the evolution of cancer treatment therapiesAnti-arthritis activity of cationic materials.Targeted gene delivery to the lung.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Gelatin-based delivery systems for cancer gene therapy.Pharmaceutical emulsions: a new approach for gene therapy.Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.Marine polysaccharides in pharmaceutical applications: an overviewThe role of cell cycle in the efficiency and activity of cancer nanomedicines.Modeling the interaction between dendrimers and nucleic acids: a molecular perspective through hierarchical scales.DNA vaccination for prostate cancer: key concepts and considerations.Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.Nano-ART and NeuroAIDS.Preparation and characterization of gelatin nanoparticles containing pDNA encoding IL-12 and their expression in CT-26 carcinoma cells.Barriers to Liposomal Gene Delivery: from Application Site to the Target.Molecular weight-dependent genetic information transfer with disulfide-linked polyethylenimine-based nonviral vectors.Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery.
P2860
Q24791038-EA3BD222-8EA3-465B-9ED8-B18FD4C0937EQ24813608-31E7B60E-0FAD-4DF0-96AA-CC055380BB85Q28659480-60E68A1E-1954-44D5-8435-5C55DAD2D510Q30433371-946A4E9E-A136-42A8-9633-095657C29AD9Q30463547-00DBB1BC-19FC-4217-9375-C85B65C9B84DQ30503526-53AE818F-CB66-4EC5-B4DE-BDE729AFFA75Q30557515-ECC2ADAE-3FF3-4B8F-B137-59D75FA5EB6DQ33392896-4F979CA5-2956-4062-902E-942A5F427EC2Q33719254-B96D9E48-BC34-4F60-BE83-9B3D8487D59FQ34378581-E989542E-2F28-4DD8-A7E6-15C22936013CQ34468023-8DBFD50F-9781-44B9-AE6E-BD8C5E0F6FAFQ34489415-AD58D96B-9626-4A34-846E-34631B19BFC4Q35488154-9D7361D9-9686-4D22-ADFA-7F8FD82188ADQ35547243-832508E4-2E9A-40D6-8AA6-3CAFAB6F602CQ35943647-43926637-F957-4D36-89AA-133AD2E10538Q36012920-E1CFBECA-BEE9-45A2-915A-F7C4BC6B5A18Q36063505-DECE9D91-E61B-40B9-A5BD-91C24AF80443Q36250777-7A6076F0-D4D8-49FA-B894-6FBAE30B821FQ36272601-2589F9C0-5881-4F08-BFF2-715140BD91D6Q36315150-D0F90673-8B3D-4ECD-AD61-2FAF3E5C58B6Q36409033-2B8F7B3F-2B67-4463-B178-394F227D7D5CQ36690285-1F662E3D-A4EA-4FF4-88E8-DE90AEDDDD6CQ37137408-18BA2D9F-1800-4F4C-9ACB-92310C05F935Q37295729-B77C0AB5-AF41-416D-87AB-17039C85D874Q37486747-6A2FB916-81E2-4AF3-9ECD-F814E555E375Q37572760-16B06A55-5C12-4A9B-9050-B176F6E83381Q37622876-17293443-ADC1-4DAA-BC36-62BD66EFEB27Q37643683-6417829F-C1C0-4532-9F7F-78B306B90D75Q37657507-9654B4E8-94F4-4E83-8DDE-4D435BC948AFQ37800376-91111D6D-3074-4469-9C58-31FE21100FBDQ38084705-097149F0-14F1-4048-9B33-FFCFB457A8FDQ38248247-E4A7893E-6849-4DAE-9088-72480E0CA3F8Q38544772-30C82B89-9EF3-451B-B4FA-736AFD3749ACQ38713376-0BD23852-6D11-40F7-8255-C6339A8B0F7BQ38777583-3ED8855D-2DC0-4760-BBDE-AEC3B74D5A05Q38823456-8D9C97FA-5A54-4119-BF91-2B4C322BE849Q39117561-D9AAAC9D-1AB3-4B69-B6FB-9FFDE011CEBCQ39147224-FA05D930-4F41-45DA-80CB-00D9A441CC24Q39296034-488B561D-0AE1-459B-8AAB-D7EFA64D8A46Q39405505-0C82F639-2C5B-40F9-AF08-1B8AB7A4C424
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gene delivery with synthetic (non viral) carriers.
@ast
Gene delivery with synthetic (non viral) carriers.
@en
Gene delivery with synthetic
@nl
type
label
Gene delivery with synthetic (non viral) carriers.
@ast
Gene delivery with synthetic (non viral) carriers.
@en
Gene delivery with synthetic
@nl
prefLabel
Gene delivery with synthetic (non viral) carriers.
@ast
Gene delivery with synthetic (non viral) carriers.
@en
Gene delivery with synthetic
@nl
P1476
Gene delivery with synthetic (non viral) carriers
@en
P2093
P356
10.1016/S0378-5173(01)00861-4
P407
P577
2001-10-01T00:00:00Z